P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma

Drug resistance is a major challenge for all oncological treatments that involve the use of cytotoxic agents. Recent therapeutic alternatives cannot circumvent the ability of cancer cells to adapt or alter the natural selection of resistant cells, so the problem persists. In neuroblastoma, recurrenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnaud-Sampaio, Vanessa Fernandes, Bento, Carolina Adriane, Glaser, Talita, Adinolfi, Elena, Ulrich, Henning, Lameu, Claudiana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458077/
https://www.ncbi.nlm.nih.gov/pubmed/36091161
http://dx.doi.org/10.3389/fonc.2022.966404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458077/
https://www.ncbi.nlm.nih.gov/pubmed/36091161
http://dx.doi.org/10.3389/fonc.2022.966404

Ejemplares similares